Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

被引：0
|
作者：
Zhou, Renke
Scheurer, Michael E.
Gilbert, Mark R.
Bondy, Melissa
Sulman, Erik P.
Yuan, Ying
Liu, Yanhong
Vera, Elizabeth
Wendland, Merideth M.
Brachman, David
Bearden, James
McGovern, Susan Lynne
Wilson, Steven S.
Judy, Kevin D.
Robins, H. Ian
Hunter, Grant Kirton
Pugh, Stephanie L.
Armstrong, Terri S.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[5] Willamette Valley Canc Inst, Eugene, OR USA
[6] Univ Arizona, Canc Ctr, Phoenix Accruals Arizona Oncol Serv Fdn, Phoenix, AZ USA
[7] Southeast Canc Control Consortium Inc, CCOP, Winston Salem, NC USA
[8] UPMC Canc Ctr, New Castle, PA USA
[9] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[10] Univ Wisconsin, Comprehens Canc Ctr, Madison, WI USA
[11] Intermountain Healthcare, Murray, UT USA
[12] NRG Oncol, Philadelphia, PA USA
[13] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2049
引用
收藏
页数：2
相关论文
共 42 条
  • [1] Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
    Scheurer, Michael E.
    Zhou, Renke
    Gilbert, Mark R.
    Bondy, Melissa L.
    Sulman, Erik P.
    Yuan, Ying
    Liu, Yanhong
    Vera, Elizabeth
    Wendland, Merideth M.
    Youssef, Emad F.
    Stieber, Volker W.
    Komaki, Ritsuko R.
    Flickinger, John C.
    Kenyon, Lawrence C.
    Robins, H. Ian
    Hunter, Grant K.
    Crocker, Ian R.
    Chao, Samuel T.
    Pugh, Stephanie L.
    Armstrong, Terri S.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [2] FINAL RISK MODEL FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON NRG ONCOLOGY'S RTOG 0825
    Armstrong, T. S.
    Gilbert, M. R.
    Bondy, M.
    Sulman, E.
    Yuan, Y.
    Zhou, R.
    Vera, E.
    Wendland, M.
    Pugh, S.
    Scheurer, M.
    NEURO-ONCOLOGY, 2017, 19 : 10 - 10
  • [3] An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology/RTOG 0525 and 0825.
    Gittleman, Haley R.
    Lim, Daniel
    Kattan, Michael W.
    Chakravarti, Arnab
    Gilbert, Mark R.
    Lassman, Andrew B.
    Lo, Simon S.
    Machtay, Mitchell
    Sloan, Andrew E.
    Sulman, Erik P.
    Tian, Devin
    Vogelbaum, Michael A.
    Wang, Tony J. C.
    Penas-Prado, Marta
    Youssef, Emad
    Blumenthal, Deborah T.
    Zhang, Peixin
    Mehta, Minesh P.
    Barnholtz-Sloan, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825
    Zhou, Renke
    Scheurer, Michael
    Vera-Bolanos, Elizabeth
    Gilbert, Mark
    Bondy, Melissa
    Sulman, Eric
    Hilsenbeck, Sue
    Wendland, Merideth
    Brachman, David
    Roof, Kevin
    Komaki, Ritsuko
    Deutsch, Melvin
    Andrews, David
    Anderson, Bethany
    Lee, R. Jeffrey
    Pugh, Stephanie
    Armstrong, Terri
    NEURO-ONCOLOGY, 2014, 16
  • [5] Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825
    Hall, W. A.
    Pugh, S. L.
    Gilbert, M. R.
    Wefel, J. S.
    Armstrong, T.
    Wendland, M. M.
    Brachman, D. G.
    Roof, K. S.
    Brown, P. D.
    Crocker, I. R.
    Robins, H. I.
    Lee, R. J.
    Chao, S. T.
    Kim, L.
    Srkalovic, G.
    Fisch, B. M.
    Mehta, M. P.
    Curran, W. J., Jr.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S110 - S110
  • [6] An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
    Gittleman, Haley
    Lim, Daniel
    Kattan, Michael W.
    Chakravarti, Arnab
    Gilbert, Mark R.
    Lassman, Andrew B.
    Lo, Simon S.
    Machtay, Mitchell
    Sloan, Andrew E.
    Sulman, Erik P.
    Tian, Devin
    Vogelbaum, Michael A.
    Wang, Tony J. C.
    Penas-Prado, Marta
    Youssef, Emad
    Blumenthal, Deborah T.
    Zhang, Peixin
    Mehta, Minesh P.
    Barnholtz-Sloan, Jill S.
    NEURO-ONCOLOGY, 2017, 19 (05) : 669 - 677
  • [7] An Independently Validated Nomogram for Individualized Estimation of Survival Among Patients With Newly Diagnosed Glioblastoma: NRG Oncology/RTOG 0525 and 0825
    Gittleman, H. R.
    Lim, D.
    Kattan, M.
    Chakravarti, A.
    Gilbert, M. R.
    Lassman, A. B.
    Lo, S. S.
    Machtay, M.
    Sloan, A. E.
    Sulman, E. P.
    Tian, D.
    Vogelbaum, M. A.
    Wang, T. J. C.
    Penas-Prado, M.
    Youssef, E.
    Blumenthal, D. T.
    Zhang, P.
    Mehta, M. P.
    Barnholtz-Sloan, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S92 - S92
  • [8] Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
    Patil, Nirav
    Somasundaram, Eashwar
    Waite, Kristin A.
    Lathia, Justin D.
    Machtay, Mitchell
    Gilbert, Mark R.
    Connor, James R.
    Rubin, Joshua B.
    Berens, Michael E.
    Buerki, Robin A.
    Choi, Serah
    Sloan, Andrew E.
    Penas-Prado, Marta
    Ashby, Lynn S.
    Blumenthal, Deborah T.
    Werner-Wasik, Maria
    Hunter, Grant K.
    Flickinger, John C.
    Wendland, Merideth M.
    Panet-Raymond, Valerie
    Robins, H. Ian
    Pugh, Stephanie L.
    Mehta, Minesh P.
    Barnholtz-Sloan, Jill S.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 363 - 372
  • [9] Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
    Nirav Patil
    Eashwar Somasundaram
    Kristin A. Waite
    Justin D. Lathia
    Mitchell Machtay
    Mark R. Gilbert
    James R. Connor
    Joshua B. Rubin
    Michael E. Berens
    Robin A. Buerki
    Serah Choi
    Andrew E. Sloan
    Marta Penas-Prado
    Lynn S. Ashby
    Deborah T. Blumenthal
    Maria Werner-Wasik
    Grant K. Hunter
    John C. Flickinger
    Merideth M. Wendland
    Valerie Panet-Raymond
    H. Ian Robins
    Stephanie L. Pugh
    Minesh P. Mehta
    Jill S. Barnholtz-Sloan
    Journal of Neuro-Oncology, 2021, 155 : 363 - 372
  • [10] BRAIN ATROPHY IN GLIOBLASTOMA PATIENTS FOLLOWING TREATMENT WITH CHEMORADIATION OR CHEMORADIATION WITH ANTI-ANGIOGENIC THERAPY IN NRG/ RTOG 0825 PARTICIPANTS
    Akintola, Oluwatosin
    Dietrich, Jorg
    Muzikansky, Alona
    Gardner, Melissa
    Youssef, Gilbert
    Huang, Raymond
    Gerstner, Elizabeth
    Wen, Patrick Y.
    Parsons, Michael
    Gilbert, Mark
    Rogers, Leland
    Lieberman, Frank
    Wendland, Merideth
    Puduvalli, Vinay
    Shrieve, Dennis
    Stieber, Volker
    Pugh, Stephanie
    Mehta, Minesh
    NEURO-ONCOLOGY, 2022, 24 : 201 - 201
12345